LUCENTIS (Ranibizumab Injection)

Date:
2026-03-25
Category:
Indication
– Neovascular age related macular degeneration
– Diabetic macular edema
– Macular edema following retinal vein occlusion
– Choroidal neovascularization
– Diabetic retinopathy
– Retinopathy of prematurity